Emla and Weight - a phase IV clinical study of FDA data

Summary:

Weight is found among people who take Emla, especially for people who are female, 40-49 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Emla and have Weight. It is created by eHealthMe based on reports of 4,645 people who have side effects when taking Emla from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 10, 2023

4,645 people reported to have side effects when taking Emla.
Among them, 13 people (0.28%) have Weight.

What is Emla?

Emla has active ingredients of lidocaine; prilocaine. eHealthMe is studying from 4,653 Emla users for its effectiveness, alternative drugs and more.

What is Weight?

Weight is found to be associated with 2,715 drugs and 2,182 conditions by eHealthMe.

Number of Emla and Weight reports submitted per year:

Time on Emla when people have Weight *:

Gender of people who have Weight when taking Emla *:

female: 92.31 %
male: 7.69 %

Age of people who have Weight when taking Emla *:

Common drugs people take besides Emla *:

Common side effects people have besides Weight *:

Joint Pain: 11 people, 84.62%
Nausea (feeling of having an urge to vomit): 11 people, 84.62%
Fatigue (feeling of tiredness): 10 people, 76.92%
Pain In Extremity: 8 people, 61.54%
Back Pain: 7 people, 53.85%
Urinary Tract Infection: 7 people, 53.85%
Weight Decreased: 7 people, 53.85%
Weakness: 7 people, 53.85%
Hypoaesthesia (reduced sense of touch or sensation): 7 people, 53.85%
Cough: 7 people, 53.85%

Common conditions people have *:

Bone Loss: 5 people, 38.46%
Osteoporosis (bones weak and more likely to break): 5 people, 38.46%
Stress And Anxiety: 4 people, 30.77%
Nausea (feeling of having an urge to vomit): 4 people, 30.77%
Constipation: 3 people, 23.08%
Upper Respiratory Tract Infection: 3 people, 23.08%
Nausea And Vomiting: 3 people, 23.08%
Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 2 people, 15.38%
Herpes Simplex (herpes simplex is a common viral infection): 2 people, 15.38%
Hypophysitis (inflammation of the pituitary gland): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Emla and have Weight?

Check whether Weight is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Weight and when was it recovered:

Weight in Emla

Expand to all the drugs that have ingredients of lidocaine; prilocaine:

Weight and drugs with ingredients of lidocaine; prilocaine (14 reports)

Alternative drugs to, pros and cons of Emla:

Emla (4,653 reports)

Common Emla side effects:

Fatigue (feeling of tiredness): 477 reports
Diarrhea: 343 reports
Nausea and vomiting: 297 reports
Fever: 287 reports
Headache (pain in head): 283 reports
Weakness: 281 reports
Rashes (redness): 247 reports
Breathing difficulty: 244 reports

Browse all side effects of Emla:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Weight treatments and more:

Weight (50,631 reports)

COVID vaccines that are related to Weight:

Common drugs associated with Weight:

All the drugs that are associated with Weight:

Weight (2,715 drugs)

Common conditions associated with Weight:

Depression: 2,066 reports
Bipolar disorder: 1,904 reports
Schizophrenia: 1,856 reports
Attention deficit hyperactivity disorder: 1,335 reports
High blood pressure: 1,334 reports
Rheumatoid arthritis: 1,226 reports
Pain: 1,051 reports

All the conditions that are associated with Weight:

Weight (2,182 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lidocaine; prilocaine (the active ingredients of Emla) and Emla (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.